IP Library Granted Patent US 8,536,222
Granted Patent B2
US 8,536,222 · App. 13/425,893 · Granted Sep 17, 2013

Addition compounds of guanidinoacetic acid

Inventors: Thomas Gastner (Engelsberg, DE); Hans-Peter Krimmer (Kirchweidach, DE)
Assignee: AlzChem AG
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,536,222
App. No.
13/425,893
Granted
Sep 17, 2013
Kind
B2
Abstract

The present invention provides new addition compounds of guanidinoacetic acid with malic acid, aspartic acid, ascorbic acid, succinic acid, pyruvic acid, fumaric acid, gluconic acid, alpha-ketoglutaric acid, pyroglutamic acid, 3-nicotinic acid, lactic acid, citric acid, maleic acid, acetic acid, formic acid, 2-hydroxybenzoic acid, L-carnitine, acetyl-L-carnitine, taurine, betaine, choline, methionine and lipoic acid as well as in the form of sodium, potassium or calcium guanidinoacetate. These addition compounds have improved physiological and therapeutic properties and are particularly suitable for use as dietary supplements, as animal feeds and in cosmetic or dermatological preparations in which especially the marked stability and good bioavailability of the addition compounds come to the fore.

Claims (23)

1. A method comprising increasing creatine in the muscle of a subject by administering to said subject a composition comprising at least one guanidinoacetic acid addition compound comprising (i) guanidinoacetic acid and (ii) malic acid, aspartic acid, ascorbic acid, succinic acid, pyruvic acid, fumaric acid, glut acid, alpha-ketoglutaric acid, pyroglutamic acid, 3-nicotinic acid, citric acid, maleic acid, acetic acid, formic acid, 2-hydroxybenzoic acid, L-carnitine, acetyl-L-carnitine, taurine, betaine, choline or lipoic acid.

2. The method of claim 1 , wherein the at least one guanidinoacetic acid addition compound comprises guanidinoacetic acid and citric acid.

3. The method of claim 1 , wherein the at least one guanidinoacetic acid addition compound comprises guanidinoacetic acid and alpha-ketoglutaric acid.

4. The method of claim 1 , wherein said composition further comprises at least one additional compound selected from the group consisting of carbohydrates, fats, amino acids, proteins, vitamins, mineral substances, trace elements, derivatives thereof and mixtures thereof.

5. The method of claim 1 , wherein said composition is in the foitu of a powder, a granulate, a lozenge, a capsule, a pellet, a solution, a fruit juice or a jelly product.

6. The method of claim 1 , wherein a sufficient amount of said composition is administered in an amount sufficient to provide a single dose of 0.001 to 1 g/kg of at least one guanidinoacetic acid addition compound per body weight of said subject.

7. The method of claim 1 , wherein a sufficient amount of said composition is administered to the subject to provide a daily dose of 0.001 to 50 g of said at least one guanidinoacetic acid addition compound.

8. The method of claim 1 , wherein said subject is a mammal.

9. The method of claim 2 , wherein said mammal is a human, dog, cat, pig, or horse.

10. The method of claim 1 , wherein the subject is a chicken.

11. The method of claim 1 , wherein said subject is a human that attends school, plays sports, is a convalescent, or is a geriatric.

12. A method comprising increasing muscle mass of a subject by administering to said subject a composition comprising at least one guanidinoacetic acid addition compound comprising (i) guanidinoacetic acid and (ii) malic acid, aspartic acid, ascorbic acid, succinic acid, pyruvic acid, fumaric acid, gluconic acid, alpha-ketoglutaric acid, pyroglutamic acid, 3-nicotinic acid, citric acid, maleic acid, acetic acid, formic acid, 2-hydroxybenzoic acid, L-carnitine, acetyl-L-carnitine, taurine, betaine, choline or lipoic acid.

13. A method comprising increasing the bioavailability of guanidinoacetic acid in a subject by administering to said subject a composition comprising at least one guanidinoacetic acid addition compound comprising (i) guanidinoacetic acid and (ii) malic acid, aspartic acid, ascorbic acid, succinic acid, pyruvic acid, fumaric acid, gluconic acid, alpha-ketoglutaric acid, pyroglutamic acid, 3-nicotinic acid, citric acid, maleic acid, acetic acid, formic acid, 2-hydroxybenzoic acid, L-carnitine, acetyl-L-carnitine, taurine, betaine, choline or lipoic acid.

14. An animal feed or dietary supplement comprising at least one guanidinoacetic acid addition compound comprising (i) guanidinoacetic acid and (ii) at least one compound selected from the group consisting of malic acid, aspartic acid, ascorbic acid, succinic acid, pyruvic acid, fumaric acid, gluconic acid, alpha-ketoglutaric acid, pyroglutamic acid, 3-nicotinic acid, lactic acid, citric acid, maleic acid, acetic acid, formic acid, 2-hydroxybenzoic acid, L-carnitine, acetyl-L-carnitine, taurine, betaine, choline, methionine and lipoic acid.

15. The animal feed or dietary supplement of claim 14 , wherein compound (ii) is selected from citric acid or alpha-ketoglutaric acid.

16. The method of claim 12 , wherein the animal feed or dietary supplement further comprises at least one additional substance selected from the group consisting of carbohydrates, fats, amino acids, proteins, vitamins, mineral substances, trace elements, derivatives thereof and mixtures thereof.

17. The method of claim 12 , wherein said animal feed or dietary supplement is in the form of a powder, a granulate, a lozenge, a capsule, a pellet, a solution, a fruit juice or a jelly product.

18. The method of claim 12 , wherein a sufficient amount of said composition is administered in an amount sufficient to provide a single dose of 0.001 to 1 g/kg of said at least one guanidinoacetic acid salt per body weight of said subject.

19. The method of claim 12 , wherein a sufficient amount of said composition is administered to the subject to provide a daily dose of 0.001 to 50 g of said at least one guanidinoacetic acid salt.

20. The method of claim 12 , wherein said subject is a mammal.

21. The method of claim 20 , wherein said mammal is a human, dog, cat, pig, or horse.

22. The method of claim 12 , wherein said animal is a chicken.

23. The method of claim 12 , wherein said subject is a human that attends school, plays sports, is a convalescent, or is a geriatric.

Assignments (2)
CHANGE OF NAME Recorded Jul 31, 2018
From: ALZCHEM AG
To: ALZCHEM TROSTBERG GMBH
Reel/Frame 046670/0167 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 31, 2012
From: GASTNER, THOMAS; KRIMMER, HANS-PETER
To: ALZCHEM AG
Reel/Frame 028297/0604 →
Priority Claims (1)
DE 10 2005 009 990 · Mar 4, 2005 · national
Continuity (2)
Continuation In Part 11885375
Related Publication 20120238629A1 · Sep 20, 2012